As it has for more than 20 years, Christie Digital Systems will once again showcase a wide range of technology during CinemaCon 2022, April 25-28 in the Milano Ballrooms I and V at Caesars Palace in Las Vegas Las Vegas.
“We’re thrilled to celebrate CinemaCon 2022 with the launch of new products,” says Brian Claypool, executive vice president, cinema, Christie. “From Xenon, RGBe to Christie RealLaser, Vive audio and a plethora of service options that provide peace of mind, Christie is committed to creating innovative solutions for cinemas of all sizes that differentiate the experience and make ownership of our products economical and easy. We have the widest range of advanced solutions for cinemas on the market, and we’re excited to introduce new Xenon and RGB pure laser projectors at the show.”
Christie will showcase its latest innovations including the CP4425-RGB and the CP4435-RGB pure laser projectors. Featuring CineLife+ electronics and RealLaser illumination for bright, immersive content, the company says these projectors are ideal for mainstream theatres. With more than 50,000 hours of stable Digital Cinema Initiative brightness, they afford many years of low maintenance operation for an advanced, yet affordable, cinema solution.
Also launching at CinemaCon are the Christie CP2420-Xe and CP4420-Xe projectors. Featuring Xenolite lamps designed for longer lamp life than ever before, and Cinelife+ electronics which offer massive advancements in signal processing and ease of use, these projectors offer reliable performance with the lowest acquisition costs in the industry.
Christie’s Professional Services include proactive maintenance, extended parts coverage, troubleshooting, onsite services, and remote monitoring capabilities.
Designed to add another layer of defense to indoor spaces, including cinemas, Christie CounterAct, with patented Care222, is first UV disinfection technology developed for use around people, according to the company. Christie CounterAct uses proprietary filtered far-UVC light to eliminate 99 percent of pathogens on surfaces in indoor spaces, including the SARS-CoV-2 coronavirus that causes COVID-19, influenza, bacteria, and other antibiotic-resistant superbugs by damaging the DNA or RNA of the pathogen, which leaves them unable to reproduce and infect humans.
Christie Digital Systems USA www.christiedigital.com